BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Genetown

  Ironwood Release: Nine In Ten Physicians Agree Target Goal For Gout Is Imperative, Yet Half Of Patients Fail To Reach It, New Survey Shows

  October 3, 2016

   · 

  6 min read
• BioMidwest

  Mettler-Toledo Release: One-Stop Blog Is The Ultimate Data Resource

  October 3, 2016

   · 

  4 min read
• Drug Development

  Allegro Ophthalmics LLC Announces Last Patient Enrolled In PACIFIC Phase IIb Clinical Trial Of Luminate For Non-Proliferative Diabetic Retinopathy

  October 3, 2016

   · 

  4 min read
• Pharm Country

  Rosetta Genomics Fortifies Intellectual Property Portfolio With Two New Patent Allowances For Its Novel MicroRNA Platform Technology

  October 3, 2016

   · 

  4 min read
• Biotech Beach

  Arcturus Therapeutics To Report Identification Of LUNAR-HBV, A Potent Combination Of Three UNA Oligomers Targeting All Hepatitis B Virus Genotypes At The AASLD Liver Meeting 2016

  October 3, 2016

   · 

  3 min read
• Pharm Country

  CytoSorbents Release: International Marketing Of CytoSorb Commences At European Association For Cardio-Thoracic Surgery Conference

  October 3, 2016

   · 

  5 min read
• GENFIT: New Scientific Data To Be Presented During Next AASLD Annual Meeting; Strong Involvement In The First-Ever NASH-TAG Conference

  October 3, 2016

   · 

  4 min read
• Recipharm AB Launches Serialisation Showcase Line

  October 3, 2016

   · 

  4 min read
• Drug Development

  Videregen’s Lead Product Granted EU Orphan Drug Status

  October 3, 2016

   · 

  3 min read
• Drug Development

  Boston’s Albireo Reports Positive Late Stage Data Results for Elobixibat

  October 3, 2016

   · 

  6 min read